[Retracted] Prophylactic Use of Antibiotics for Postsurgical Infection in c-TACE and DEB-TACE High-Risk Patients: A Case-Control Study

Table 2

Univariate, multivariate, and trend analysis of outcomes.

Variables	Postoperative leukocyte count >9.5 × 10^9/L group (n = 28)				Postoperative infection group (n = 14)
	Univariate analysis		Multivariate analysis		Univariate analysis		Multivariate analysis
	p value	Odds ratio (95% CI)	p value	Odds ratio (95% CI)	p value	Odds ratio(95% CI)	p value	Odds ratio(95% CI)
Age (years)	0.093	0.705(0.470–1.060)	0.152	0.720(0.460–1.128)
≤ 39	0.050	14.677(0.999–215.310)	0.073	16.087(0.776–333.645)	0.176	4.444(0.512–38.611)
40–49	0.139	6.000(0.557–64.576)	0.126	7.462(0.568–98.016)	0.581	0.513(0.048–5.477)
50–59	0.094	6.286(0.730–54.099)	0.073	8.022(0.825–78.002)	0.823	0.833(0.169–4.118)
60–69	0.088	6.160(0.762–49.793)	0.061	8.257(0.909–75.019)	0.314	0.444(0.092–2.518)
70+	Reference		Reference		Reference		Reference
Sex (male/female)	0.883	0.927(0.337–2.549)			0.223	3.640(0.456–29.039)
Diabetes history (yes/no)	0.085	2.880(0.863–9.610)	0.025	5.112(1.229–21.264)	0.488	1.773(0.351–8.954)
History of biliary surgery (yes/no)	0.593	0.654(0.138–3.104)			0.999	0.000(0.000–0.000)
Gallstone (yes/no)	0.973	1.021(0.313–3.332)			0.003	6.107(1.848–20.179)	0.084	3.626(0.843–15.597)
Operation mode (c-tace/deb-tace)	0.504	1.394(0.526–3.691)			0.922	1.070(0.278–4.116)
Number of TACE (n)	0.919	0.988(0.788–1.240)			0.075	0.515(0.248–1.068)	0.051	0.394(0.154–1.005)
Preoperative albumin value (g/L)	0.270	0.566(0.206–1.556)	0.289^∗	0.5610.192–1.633)	0.011	11.097(1.738–70.873)	0.046	8.824(1.041–74.773)
≥40 g/L	Reference				Reference		Reference
≥25 g/L,＜40 g/L	0.037	0.326(0.114–0.934)	0.082	0.364(0.117–1.136)	0.642	1.651(0.199–13.693)	0.455	2.332(0.253–21.472)
＜25 g/L	0.626	1.714(0.196–15.019)	0.821	1.335(0.110–16.147)	0.010	54.000(2.611–11116.898)	0.030	153.118(1.631–14372.331)
Preoperative preventive medication (yes/no)	0.614	0.808(0.353–1.850)			0.290	1.857(0.590–5.847)

 = p for trend.